Abstract | PURPOSE: METHODS: In this prospective randomized study, 207 eyes of 171 cataract patients underwent phacoemulsification using the dispersive-viscoadaptive soft-shell technique (V-group, 102 eyes) with Viscoat and Healon5 or the dispersive-cohesive soft-shell technique (C-group, 105 eyes) with Viscoat and a cohesive agent (Opegan-Hi). Each group was divided into two subgroups depending on the amount of ultrasound (%Min) used during phacoemulsification. Corneal endothelial cell density was examined preoperatively and 3 months postoperatively. The endothelial cell loss was compared between the two groups, and also between the subgroups. RESULTS: The mean endothelial cell loss 3 months after surgery was 8.4 +/- 5.6% standard deviation (SD) in the V-group and 8.2 +/- 6.2% in the C-group (P = 0.787). In the subgroups with ultrasound of 10 %Min or less, the mean endothelial cell loss 3 months after surgery was 6.6 +/- 4.6% in the V-group and 5.5 +/- 5.0% in the C-group (P = 0.104). In the subgroups with ultrasound of over 10 %Min, this value was 10.6 +/- 6.3% in the V-group and 11.9 +/- 5.7% in the C-group (P = 0.413). The correlation coefficient of the endothelial cell loss rate and %Min was 0.245 (P = 0.0129) in the V-group and 0.501 (P < 0.0001) in the C-group. CONCLUSION: The dispersive-viscoadaptive soft-shell technique is as effective as the dispersive-cohesive soft-shell technique in protecting corneal endothelial cells during phacoemulsification regardless of the amount of ultrasound energy used.
|
Authors | Masaki Sato, Chiho Sakata, Mikako Yabe, Tetsuro Oshika |
Journal | Acta ophthalmologica
(Acta Ophthalmol)
Vol. 86
Issue 1
Pg. 65-70
(Feb 2008)
ISSN: 1755-3768 [Electronic] England |
PMID | 17908256
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Drug Combinations
- chondroitin sulfate, sodium hyaluronate drug combination
- Hyaluronic Acid
- Chondroitin
- Chondroitin Sulfates
|
Topics |
- Aged
- Aged, 80 and over
- Cataract Extraction
(methods)
- Cell Count
- Chondroitin
(therapeutic use)
- Chondroitin Sulfates
- Cytoprotection
- Drug Combinations
- Endothelium, Corneal
(diagnostic imaging, drug effects, pathology)
- Female
- Humans
- Hyaluronic Acid
(therapeutic use)
- Intraocular Pressure
- Intraoperative Care
- Male
- Middle Aged
- Phacoemulsification
- Postoperative Period
- Time Factors
- Ultrasonography
|